2003
DOI: 10.1016/s1052-3057(03)00037-5
|View full text |Cite
|
Sign up to set email alerts
|

The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
116
0
2

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 74 publications
(123 citation statements)
references
References 32 publications
5
116
0
2
Order By: Relevance
“…10,11 Indirect evidence also suggested that nitrates lowered BP without attenuating CBF, confirming preclinical data. 12-14 Sodium nitroprusside did not alter CBF, assessed qualitatively using single-photon emission computed tomography.…”
supporting
confidence: 55%
See 3 more Smart Citations
“…10,11 Indirect evidence also suggested that nitrates lowered BP without attenuating CBF, confirming preclinical data. 12-14 Sodium nitroprusside did not alter CBF, assessed qualitatively using single-photon emission computed tomography.…”
supporting
confidence: 55%
“…21 Duplicate mean, systolic, and diastolic velocities and pulsatility index were measured separately for affected and unaffected hemispheres. 10,11 BP was measured immediately before the baseline xenon CT scan and immediately after the posttreatment scan. Duplicate measurements of peripheral systolic and diastolic BP were measured in the nonhemiparetic arm with a validated digital readout oscillometric device (Omron HEM-705CP, Omron Corp).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…[11][12][13] A non randomised comparison of intravenous sodium nitroprusside in patients with acute ischaemic stroke and normal older volunteers was excluded. [18] The trials included a total of 145 patients (NO donor 93, control 52) and each assessed transdermal glyceryl trinitrate (GTN), an organic nitrate.…”
Section: Trial Characteristicsmentioning
confidence: 99%